...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor.
【24h】

Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor.

机译:MK-801诱导的运动活性在多巴胺D3受体敲除小鼠中增强,但是通过多巴胺D3受体抑制多巴胺D3 / D2拮抗剂。

获取原文
获取原文并翻译 | 示例
           

摘要

There are contradictory data regarding the role of the dopamine D(3) receptor in regulating N-methyl-d-aspartate (NMDA) receptor antagonist (e.g., dizocilpine) induced hyperactivity. The purpose of the present study was to examine the interaction of dopamine D(3) receptor preferring antagonists U99194A (5,6-dimethoxy-2(dipropylamino)indan) and S33804 ((3aR,9bS)-N[4-(8-cyano-1,3a,4,9b-tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2-yl)-b utyl] (4-phenyl)benzamide)) with dizocilpine (MK-801)-induced hyperactivity in wild type (WT) and dopamine D(3) receptor mutant (D(3)R KO) mice. D(3)R KO and WT mice were administered vehicle (saline, 1 ml/100g body weight, i.p.), or S33084 (1.0mg/kg.) and U99194A (0.1mg/kg or 0.01 mg/kg), and horizontal and vertical activity counts were recorded for 30 min. Mice were then treated with vehicle or MK-801 (0.12 mg/kg i.p.) and returned to the open field for an additional 55 min. D(3)R KO mice showed a significantly higher level of locomotor and rearing activity during the 1st 30 min after vehicle treatment compared to WT mice. MK-801-hyperactivity was significantly higher in D(3)R KO mice than WT mice. Dopamine D(3) receptor preferring antagonists suppressed the locomotor activity response to MK-801 to an equal extent in D(3)R KO and WT mice. The results confirm that MK-801-induced hyperactivity and novelty-induced behavioral activity and rearing are enhanced in D(3)R KO mice, but suppression by dopamine D(3) receptor preferring antagonists is not through dopamine D(3) receptor antagonism.
机译:存在关于多巴胺D(3)受体在调节N-甲基-D-天冬氨酸(NMDA)受体拮抗剂(例如,Dizocilpine)诱导的多动的多动的作用的矛盾数据。本研究的目的是检查多巴胺D(3)受体偏拮抗剂U99194A(5,6-二甲氧基-2(偶氮氨基)indan)和S33804((3AR,9bs)-N [4-(8-氰基1,3a,4,9b-四氢-3h-苯并吡喃[3,4-c]吡咯-2-基)-b utyl](4-苯基)苯甲酰胺)用Dizocilpine(MK-801) - 诱导的多动在野生型(WT)和多巴胺D(3)受体突变体(D(3)R KO)小鼠。 D(3)R KO和WT小鼠施用载体(盐水,1mL / 100g体重,IP)或S33084(1.0mg / kg。)和U99194a(0.1mg / kg或0.01 mg / kg),水平并记录垂直活动计数30分钟。然后用载体或MK-801(0.12mg / kg I.P)处理小鼠并返回开放场,另外55分钟。 D(3)R KO小鼠在与WT小鼠相比,在载体治疗后的第1次30分钟内显示出显着更高水平的运动和饲养活性。 D(3)R KO小鼠的MK-801-多动显着高于WT小鼠。多巴胺D(3)受体优选拮抗剂将运动活性抑制在D(3)R KO和WT小鼠中的同等程度上抑制了对MK-801的响应。结果证实,MK-801诱导的多动和新诱导的行为活性和饲养在D(3)R KO小鼠中增强,但是由多巴胺D(3)受体偏拮抗剂的抑制不是通过多巴胺D(3)受体拮抗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号